Ocular Therapeutix Inc. buy BiotechBee
Start price
07.09.22
/
60%
€5.70
Target price
31.12.24
€10.00
Performance (%)
43.52%
End price
14.12.24
€8.18
Summary
This prediction ended on 14.12.24 with a price of €8.18. With a performance of 43.52% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | -5.333% | -5.333% | -30.015% | 71.746% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
According to BiotechBee what are the pros and cons of Ocular Therapeutix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ocular Therapeutix Inc.
Buy beendet

